Documente Academic
Documente Profesional
Documente Cultură
Contenido
Definicin
Epidemiologia
Factores de riesgo
Fisiopatologia
Diagnostico
Tratamiento
2
Definicin
Las
nefropatas
crnicas
son
enfermedades
con
diferentes
procesos fisiopatolgicos.
se
define
como
la
presencia
persistente durante al menos 3
meses de alteraciones estructurales
o funcionales del rin.
Definicin
Criterios para la definicin de Enfermedad renal crnica (K/DOQUI)
Dao renal por 3 meses, definido por anormalidades estructurales o
funcionales del rin con o sin disminucin de la filtracin glomerular,
pudiendo presentar disminucin de sta, manifestada por :
Anormalidades patolgicas
Filtracin glomerular
Descripcin
90 ml/min/1.73m2
60-89 ml/min/1.73m2
30-59 ml/min/1.73m2
15-29 ml/min/1.73m2
< 15 ml/min/1.73m2 (o
dilisis)
Insuficiencia renal
Epidemiologa
Problema de salud mundial.
World Health Report 2002 y Global Burden of Disease project:
Enfermedades del rin y tracto urinario causan 850,000
muertes al ao y 15,010,167 pacientes discapacitados al
ao.
project.
Available
at
6
Epidemiologa
Se incluy a 31.712 pacientes de
127 hospitales generales de 21
estados de la Republica Mexicana,
20.702 (66%) en tratamiento de
DP y 11.010 (34%) de HD (34%)
Hipertensin
Diabetes mellitus
Enfermedades autoinmunitarias
Antecedentes familiares de nefropatias
Episodio previo de IRA
Proteinuria
Anomalias estruccturales de las vias urinarias
APOL1 en africanos (glomeruloesclerosis
segmentaria focal)
8
Definicin
Ejemplos
De progresin
Fase final
Incrementan la morbimortalidad en la
insuficiencia renal.
-Segerer S, Kretzler M, Strutz F et al. Mechanisms of tissue injury and repair in renal diseases. In: Schrier
R (ed). Diseases of the Kidney and Urinary Tract. Lippincott, Philadelphia, 2007.
-Schlondorff D. Overview of factors contributing to the athophysiology of progressive renal disease.
International Society of Nephrology. 2008. http://www.kidney-international.org
14
16
Meguid A, Bello K. Chronic kidney disease: the global challenge. Lancet 2005;
365: 33140.
20
-Besarab A, Levin A. Defining a renal anemia management period.AmJ Kidney Dis 2000;36: S1323.
-McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic
kidney disease. Curr Med Res Opin 2004;20:150110.
21
-Thomas R, Kanso A, Sedor J. Chronic Kidney Disease and Its Complications. Prim Care Clin Office
Pract 35 (2008) 329344.
-Lee GH, Benner D, Regidor DL, et al. Impact of kidney bone disease and its
22 management on
survival of patients on dialysis. J Ren Nutr 2007;17:3844.
Thomas R, Kanso A, Sedor J. Chronic Kidney Disease and Its Complications. Prim
Care Clin Office Pract 35 (2008) 329344
23
K/DOQI: TA <130/85mmHg.
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease
in chronic renal disease. Am J Kidney Dis 1998;32:S1129.
24
-Arnadottir M, NilssonEhle P. Has parathyroid hormone any influence on lipid metabolism in chronic
renal failure? Nephrol Dial Transplant 1995;10:23812.
-Thomas R, Kanso A, Sedor J. Chronic Kidney Disease and Its Complications. Prim Care Clin Office
25
Pract 35 (2008) 329344.
26
Meyer T, Hostetter T.
2007;357:1316-25.
-Vassalotti J, Stevens L, Levey A. Testing for Chronic Kidney Disease: A Position Statement From the
National Kidney Foundation. Am J Kidney Dis. 2007, 50:169-180.
-Lederer E, Ouseph R. Chronic Kidney Disease. American Journal of Kidney Diseases,
Vol 49, No 1
28
(January), 2007: pp 162-171.
Definicin
<30
<20
<3
<30
Normal
30-300
20-200
3-30
30-300
Microalbuminuria
>300
>200
>30
>300
Macroalbuminuria
la
concentracin
30
de
la
32
33
Vassalotti J, Stevens L, Levey A. Testing for Chronic Kidney Disease: A Position Statement From the
National Kidney Foundation. Am J Kidney Dis. 2007, 50:169-180.
35
36
37
39
.
Singh A, Brenner B. Dilisis en el tratamiento de la insuficincia renal. En: Harriso,
Principios de Medicina Interna. Editores Kasper D, Fauci A, Longo D et al. Mxico:
41
McGraw-Hill Interamericana. 2005,1835-39
GRACIAS